The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database

  • Kim, Ji-Won (Division of Rheumatology, Department of Internal Medicine, Catholic University of Daegu School of Medicine) ;
  • Kwak, Sang Gyu (Department of Medical Statistics, Catholic University of Daegu School of Medicine) ;
  • Park, Sung-Hoon (Division of Rheumatology, Department of Internal Medicine, Catholic University of Daegu School of Medicine)
  • Received : 2016.12.26
  • Accepted : 2017.01.17
  • Published : 2018.01.01
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

Supported by : Catholic University of Daegu

References

  1. Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012;64:1431-1446. https://doi.org/10.1002/acr.21772
  2. Goicoechea M, Garcia de Vinuesa S, Verdalles U, et al. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis 2015;65:543-549. https://doi.org/10.1053/j.ajkd.2014.11.016
  3. Kuo CF, Grainge MJ, See LC, et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther 2015;17:13. https://doi.org/10.1186/s13075-015-0522-8
  4. Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 2015;74:661-667.
  5. Dehlin M, Drivelegka P, Sigurdardottir V, Svard A, Jacobsson LT. Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther 2016;18:164. https://doi.org/10.1186/s13075-016-1062-6

Cited by

  1. Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: A national study vol.14, pp.1, 2018, https://doi.org/10.1371/journal.pone.0210487
  2. The Role of a “Treat-to-Target” Approach in the Long-Term Renal Outcomes of Patients with Gout vol.8, pp.7, 2018, https://doi.org/10.3390/jcm8071067
  3. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors vol.16, pp.7, 2018, https://doi.org/10.1038/s41584-020-0441-1
  4. Clinical Study Using Healthcare Claims Database vol.28, pp.3, 2018, https://doi.org/10.4078/jrd.2021.28.3.119
  5. Incidence, Prevalence, and Burden of Gout in the Veterans Health Administration vol.73, pp.9, 2018, https://doi.org/10.1002/acr.24339
  6. Pharmacotherapy for gout vol.64, pp.11, 2018, https://doi.org/10.5124/jkma.2021.64.11.772